Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:
The good — Iovance has launches Amtagvi 
The bad — FDA rejected Theratechnologies HIV instramuscular injection 
The ugly — BioMarin receives a subpoena from the DOJ

[The good, the bad, the ugly] Editor's Review week of March 4

The Off Script podcast offers in-depth interviews and discussions with industry experts about hot-button topics in pharma, and goes behind the scenes of Pharma Manufacturing’s print and online coverage, which follows the industry’s biggest issues surrounding scale-up, technology innovations, regulations and more